205 related articles for article (PubMed ID: 29084172)
1. Benzoic Acid Derivatives with Trypanocidal Activity: Enzymatic Analysis and Molecular Docking Studies toward Trans-Sialidase.
Kashif M; Moreno-Herrera A; Villalobos-Rocha JC; Nogueda-Torres B; Pérez-Villanueva J; Rodríguez-Villar K; Medina-Franco JL; de Andrade P; Carvalho I; Rivera G
Molecules; 2017 Oct; 22(11):. PubMed ID: 29084172
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular docking and biological evaluation of novel phthaloyl derivatives of 3-amino-3-aryl propionic acids as inhibitors of Trypanosoma cruzi trans-sialidase.
Kashif M; Chacón-Vargas KF; López-Cedillo JC; Nogueda-Torres B; Paz-González AD; Ramírez-Moreno E; Agusti R; Uhrig ML; Reyes-Arellano A; Peralta-Cruz J; Ashfaq M; Rivera G
Eur J Med Chem; 2018 Aug; 156():252-268. PubMed ID: 30006170
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in trans-sialidase inhibitors of Trypanosoma cruzi.
Kashif M; Moreno-Herrera A; Lara-Ramirez EE; Ramírez-Moreno E; Bocanegra-García V; Ashfaq M; Rivera G
J Drug Target; 2017 Jul; 25(6):485-498. PubMed ID: 28140698
[TBL] [Abstract][Full Text] [Related]
4. Structure-Based Virtual Screening of New Benzoic Acid Derivatives as Trypanosoma cruzi Trans-sialidase Inhibitors.
Vázquez-Jiménez LK; Paz-González AD; Juárez-Saldivar A; Uhrig ML; Agusti R; Reyes-Arellano A; Nogueda-Torres B; Rivera G
Med Chem; 2021; 17(7):724-731. PubMed ID: 32370720
[TBL] [Abstract][Full Text] [Related]
5. The synthesis and kinetic evaluation of aryl α-aminophosphonates as novel inhibitors of T. cruzi trans-sialidase.
Chen Z; Marcé P; Resende R; Alzari PM; Frasch AC; van den Elsen JMH; Crennell SJ; Watts AG
Eur J Med Chem; 2018 Oct; 158():25-33. PubMed ID: 30199703
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents.
Elizondo-Jimenez S; Moreno-Herrera A; Reyes-Olivares R; Dorantes-Gonzalez E; Nogueda-Torres B; Oliveira EAG; Romeiro NC; Lima LM; Palos I; Rivera G
Med Chem; 2017; 13(2):149-158. PubMed ID: 27396731
[TBL] [Abstract][Full Text] [Related]
7. An in vitro and in vivo evaluation of new potential trans-sialidase inhibitors of Trypanosoma cruzi predicted by a computational drug repositioning method.
Lara-Ramirez EE; López-Cedillo JC; Nogueda-Torres B; Kashif M; Garcia-Perez C; Bocanegra-Garcia V; Agusti R; Uhrig ML; Rivera G
Eur J Med Chem; 2017 May; 132():249-261. PubMed ID: 28364659
[TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis).
Miller BR; Roitberg AE
Future Med Chem; 2013 Oct; 5(15):1889-900. PubMed ID: 24144418
[TBL] [Abstract][Full Text] [Related]
9. Effect of 4-amino-3-nitrobenzoic acid on the expression level of the trans-sialidase gene in Trypanosoma cruzi epimastigotes.
Vázquez-Jiménez LK; Paz-González AD; Kashif M; Juárez-Rendón KJ; Nogueda-Torres B; Bocanegra-García V; Rivera G
Pak J Pharm Sci; 2019 Mar; 32(2 (Supplementary)):825-829. PubMed ID: 31103978
[TBL] [Abstract][Full Text] [Related]
10. Donor substrate binding to trans-sialidase of Trypanosoma cruzi as studied by STD NMR.
Blume A; Neubacher B; Thiem J; Peters T
Carbohydr Res; 2007 Sep; 342(12-13):1904-9. PubMed ID: 17597593
[TBL] [Abstract][Full Text] [Related]
11. Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies.
Palos I; Lara-Ramirez EE; Lopez-Cedillo JC; Garcia-Perez C; Kashif M; Bocanegra-Garcia V; Nogueda-Torres B; Rivera G
Molecules; 2017 Jun; 22(6):. PubMed ID: 28629155
[TBL] [Abstract][Full Text] [Related]
12. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
Neres J; Bryce RA; Douglas KT
Drug Discov Today; 2008 Feb; 13(3-4):110-7. PubMed ID: 18275908
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and enzymatic evaluation of 3-O-substituted aryl β-D-galactopyranosides as inhibitors of Trypanosoma cruzi trans-sialidase.
Silva BL; S Filho JD; Andrade P; Carvalho I; Alves RJ
Bioorg Med Chem Lett; 2014 Sep; 24(18):4529-4532. PubMed ID: 25149510
[TBL] [Abstract][Full Text] [Related]
14. Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidase.
Neres J; Bonnet P; Edwards PN; Kotian PL; Buschiazzo A; Alzari PM; Bryce RA; Douglas KT
Bioorg Med Chem; 2007 Mar; 15(5):2106-19. PubMed ID: 17218104
[TBL] [Abstract][Full Text] [Related]
15. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
16. Binding of triazole-linked galactosyl arylsulfonamides to galectin-3 affects Trypanosoma cruzi cell invasion.
Marchiori MF; Riul TB; Oliveira Bortot L; Andrade P; Junqueira GG; Foca G; Doti N; Ruvo M; Dias-Baruffi M; Carvalho I; Campo VL
Bioorg Med Chem; 2017 Nov; 25(21):6049-6059. PubMed ID: 29032929
[TBL] [Abstract][Full Text] [Related]
17. Insights into Anti-Trypanosomal Agents Based on Synthetic Glycoconjugates.
Campo VL; Marchiori MF; Carvalho I
Curr Top Med Chem; 2018; 18(5):382-396. PubMed ID: 29741138
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking.
Silva BNM; Sales Junior PA; Romanha AJ; Murta SMF; Lima CHS; Albuquerque MG; D'Elia E; Rodrigues JGA; Ferreira VF; Silva FC; Pinto AC; Silva BV
Med Chem; 2019; 15(3):240-256. PubMed ID: 30332972
[TBL] [Abstract][Full Text] [Related]
19. Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives.
Kim JH; Ryu HW; Shim JH; Park KH; Withers SG
Chembiochem; 2009 Oct; 10(15):2475-9. PubMed ID: 19780074
[TBL] [Abstract][Full Text] [Related]
20. The high resolution structures of free and inhibitor-bound Trypanosoma rangeli sialidase and its comparison with T. cruzi trans-sialidase.
Amaya MF; Buschiazzo A; Nguyen T; Alzari PM
J Mol Biol; 2003 Jan; 325(4):773-84. PubMed ID: 12507479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
